Health burden of pertussis in infants and children

David P Greenberg1, Carl-Heinz Wirsing von König, Ulrich Heininger

  • 1University of Pittsburgh School of Medicine, Division of Allergy, Immunology and Infectious Diseases, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA. David.Greenberg@sanofipasteur.com

Insights

Pertussis (whooping cough) incidence has decreased with vaccination, but remains a severe threat to infants. Protecting young children before full immunization is crucial to prevent serious complications and mortality.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Vaccination has dramatically reduced pertussis (whooping cough) incidence globally.
  • Despite vaccination, pertussis remains a significant public health concern, especially for infants.
  • Infants experience the highest rates of pertussis-related hospitalization, complications, and mortality.

Purpose of the Study:

  • To assess the true health burden of pertussis in infants.
  • To identify strategies for combating the transmission and infection of Bordetella pertussis.
  • To explore methods for preventing disease spread to infants before primary immunization completion.

Main Methods:

  • Review of pertussis incidence data in vaccinated populations.
  • Analysis of morbidity and mortality rates in infants compared to other age groups.
  • Assessment of complications associated with infant pertussis.

Main Results:

  • Pertussis, while milder in older individuals, poses a severe risk to unvaccinated or incompletely immunized infants.
  • Infant complications include pneumonia, encephalopathy, meningoencephalitis, apnea, and cyanosis.
  • Preventing transmission to infants before completing their immunization series is essential.

Conclusions:

  • Pertussis remains a critical public health issue, particularly for vulnerable infants.
  • The Global Pertussis Initiative aims to mitigate the impact of Bordetella pertussis.
  • Strategies to protect infants from pertussis are urgently needed.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Vaccinations01:51

Vaccinations

Overview
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...